301 related articles for article (PubMed ID: 22471370)
21. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
[TBL] [Abstract][Full Text] [Related]
22. Brazilein-induced contraction of rat arterial smooth muscle involves activation of Ca2+ entry and ROK, ERK pathways.
Shen J; Yip S; Wang Z; Wang W; Xing D; Du L
Eur J Pharmacol; 2008 Feb; 580(3):366-71. PubMed ID: 18177858
[TBL] [Abstract][Full Text] [Related]
23. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
[TBL] [Abstract][Full Text] [Related]
24. Metabotropic regulation of RhoA/Rho-associated kinase by L-type Ca2+ channels: new mechanism for depolarization-evoked mammalian arterial contraction.
Fernández-Tenorio M; Porras-González C; Castellano A; Del Valle-Rodríguez A; López-Barneo J; Ureña J
Circ Res; 2011 May; 108(11):1348-57. PubMed ID: 21493898
[TBL] [Abstract][Full Text] [Related]
25. Marrubenol interacts with the phenylalkylamine binding site of the L-type calcium channel.
El Bardai S; Hamaide MC; Lyoussi B; Quetin-Leclercq J; Morel N; Wibo M
Eur J Pharmacol; 2004 May; 492(2-3):269-72. PubMed ID: 15178374
[TBL] [Abstract][Full Text] [Related]
26. Vasorelaxing and receptor binding properties of NZ-105, a novel dihydropyridine derivative, in isolated rabbit aorta.
Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
Arch Int Pharmacodyn Ther; 1991; 312():86-103. PubMed ID: 1663336
[TBL] [Abstract][Full Text] [Related]
27. Nifedipine and alpha adrenoceptors in rat aorta. II. Role of extracellular calcium in enhanced alpha-2 adrenoceptor-mediated contraction in diabetes.
Scarborough NL; Carrier GO
J Pharmacol Exp Ther; 1984 Dec; 231(3):603-9. PubMed ID: 6094794
[TBL] [Abstract][Full Text] [Related]
28. In vitro and ex vivo Ca-antagonistic effect of 2-methoxyethyl(E)-3-phenyl-2-propen-1-yl(+/-)-1,4-dihydro-2,6-dimethyl- 4-(3- nitrophenyl)pyridine-3,5-dicarboxylate (FRC-8653), a new dihydropyridine derivative.
Hosono M; Iida H; Ikeda K; Hayashi Y; Dohmoto H; Hashiguchi Y; Yamamoto H; Watanabe N; Yoshimoto R
J Pharmacobiodyn; 1992 Oct; 15(10):547-53. PubMed ID: 1494104
[TBL] [Abstract][Full Text] [Related]
29. Heterogeneity of L- and T-channels in the vasculature: rationale for the efficacy of combined L- and T-blockade.
Ball CJ; Wilson DP; Turner SP; Saint DA; Beltrame JF
Hypertension; 2009 Apr; 53(4):654-60. PubMed ID: 19237682
[TBL] [Abstract][Full Text] [Related]
30. Effects of oxodipine on isolated rabbit aorta and mesenteric resistance vessels.
Tejerina T; Cauvin C; Tamargo J
Eur J Pharmacol; 1992 Aug; 219(2):279-84. PubMed ID: 1425952
[TBL] [Abstract][Full Text] [Related]
31. Comparative study of elgodipine and nisoldipine on the contractile responses of various isolated blood vessels.
Chulia T; Gonzalez P; Del Rio M; Tejerina T
Eur J Pharmacol; 1995 Oct; 285(2):115-22. PubMed ID: 8566128
[TBL] [Abstract][Full Text] [Related]
32. Intracellular Ca2+ silences L-type Ca2+ channels in mesenteric veins: mechanism of venous smooth muscle resistance to calcium channel blockers.
Thakali KM; Kharade SV; Sonkusare SK; Rhee SW; Stimers JR; Rusch NJ
Circ Res; 2010 Mar; 106(4):739-47. PubMed ID: 20044515
[TBL] [Abstract][Full Text] [Related]
33. L-type Ca2+ channel blockers inhibit the window contraction of mouse aorta segments with high affinity.
Michiels CF; Van Hove CE; Martinet W; De Meyer GR; Fransen P
Eur J Pharmacol; 2014 Sep; 738():170-8. PubMed ID: 24886884
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory action of niflumic acid on noradrenaline- and 5-hydroxytryptamine-induced pressor responses in the isolated mesenteric vascular bed of the rat.
Criddle DN; de Moura RS; Greenwood IA; Large WA
Br J Pharmacol; 1997 Mar; 120(5):813-8. PubMed ID: 9138686
[TBL] [Abstract][Full Text] [Related]
35. Effects of manidipine and other calcium antagonists on rat renal arcuate arteries.
Pfaffendorf M; Mathy MJ; van Zwieten PA
Am Heart J; 1993 Feb; 125(2 Pt 2):571-7. PubMed ID: 8430602
[TBL] [Abstract][Full Text] [Related]
36. Cardiovascular properties of LF 2.0254, a new potent vasoselective calcium channel blocker with a slow onset of action.
Pruneau D; Roy F; Brown NL
Fundam Clin Pharmacol; 1990; 4(2):223-43. PubMed ID: 2112508
[TBL] [Abstract][Full Text] [Related]
37. Selectivity of Ca
Takahara A; Nozaki S; Ishiguro A; Okamura K; Cao X; Aimoto M; Nagasawa Y
J Pharmacol Sci; 2018 May; 137(1):98-100. PubMed ID: 29709270
[TBL] [Abstract][Full Text] [Related]
38. Contraction of human colonic circular smooth muscle cells is inhibited by the calcium channel blocker pinaverium bromide.
Boyer JC; Magous R; Christen MO; Balmes JL; Bali JP
Cell Calcium; 2001 Jun; 29(6):429-38. PubMed ID: 11352508
[TBL] [Abstract][Full Text] [Related]
39. [Ionic mechanisms of carbon monoxide action on the contractile properties of smooth muscles of the blood vessels].
Baskakov MB; Zheludeva AS; Gusakova SV; Smagliĭ LV; Aleĭnik AN; Ianchuk PI; Medvedev MA; Orlov SN
Fiziol Zh (1994); 2013; 59(3):18-24. PubMed ID: 23957160
[TBL] [Abstract][Full Text] [Related]
40. Effects of acidosis or alkalosis on the actions of nifedipine on excitation-contraction coupling in the rat tail artery.
Achike FI; Mohamad R; Dai S; Ogle CW
Clin Exp Pharmacol Physiol; 1997; 24(9-10):692-6. PubMed ID: 9315371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
